Literature DB >> 21683981

Prognostic significance of mitotic figures in metastatic mammary ductal carcinoma to the lymph nodes.

Takahiro Hasebe1, Motoki Iwasaki, Sadako Akashi-Tanaka, Takashi Hojo, Tatsuhiro Shibata, Yuko Sasajima, Takayuki Kinoshita, Hitoshi Tsuda.   

Abstract

We previously reported that the number of mitotic figures in metastatic mammary carcinoma to the lymph nodes accurately predicted the outcome of patients with invasive ductal carcinoma with nodal metastasis. To confirm these previous findings, the present study investigated the number of mitotic figures and other histologic characteristics in metastatic mammary carcinoma to the lymph nodes and their associations with patient outcome according to nodal status and the histologic grade of primary invasive ductal carcinomas in a different series of 1039 patients with invasive ductal carcinoma. Multivariate analyses examining well-known clinicopathologic factors, the number of mitotic figures in the primary invasive ductal carcinomas, the grading system for lymph vessel tumor emboli, the p53 Allred score risk classes of tumor-stromal fibroblasts forming and not forming a fibrotic focus, and 9 histologic features of metastatic mammary carcinoma to the lymph nodes were performed. The presence of 6 or more mitotic figures in metastatic mammary carcinoma to the lymph nodes significantly increased the hazard ratios for tumor recurrence and tumor-related death among patients with invasive ductal carcinoma as a whole, those with nodal metastasis, and those with a histologic grade of 2 or 3. The presence of 6 or more mitotic figures in metastatic mammary carcinoma to the lymph nodes also significantly increased the hazard ratio for tumor recurrence among patients with histologic grade 1 invasive ductal carcinoma. In conclusion, this study clearly confirmed the excellent outcome predictive power of the number of mitotic figures in metastatic mammary carcinoma to the lymph nodes.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21683981     DOI: 10.1016/j.humpath.2011.02.015

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  3 in total

1.  Evaluation of the R2* value in invasive ductal carcinoma with respect to hypoxic-related prognostic factors using iterative decomposition of water and fat with echo asymmetry and least-squares emission (IDEAL).

Authors:  Mari Miyata; Takatoshi Aoki; Shohei Shimajiri; Atsuji Matsuyama; Shunsuke Kinoshita; Masami Fujii; Takefumi Katsuki; Yuzuru Inoue; Yoshika Nagata; Yuko Tashima; Yukunori Korogi
Journal:  Eur Radiol       Date:  2017-04-11       Impact factor: 5.315

2.  Modified primary tumour/vessel tumour/nodal tumour classification for patients with invasive ductal carcinoma of the breast.

Authors:  T Hasebe; M Iwasaki; S Akashi-Tanaka; T Hojo; T Shibata; Y Sasajima; T Kinoshita; H Tsuda
Journal:  Br J Cancer       Date:  2011-08-02       Impact factor: 7.640

3.  Evaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast Cancer.

Authors:  Sura Aziz; Elisabeth Wik; Gøril Knutsvik; Tor Audun Klingen; Ying Chen; Benedicte Davidsen; Hans Aas; Turid Aas; Lars A Akslen
Journal:  PLoS One       Date:  2016-03-08       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.